26416646|t|CALHM1 and its polymorphism P86L differentially control Ca2+homeostasis, mitogen-activated protein kinase signaling, and cell vulnerability upon exposure to amyloid beta.
26416646|a|The mutated form of the Ca2+channel CALHM1 (Ca2+homeostasis modulator 1), P86L-CALHM1, has been correlated with early onset of Alzheimer's disease (AD). P86L-CALHM1 increases production of amyloid beta (Abeta) upon extracellular Ca2+removal and its subsequent addback. The aim of this study was to investigate the effect of the overexpression of CALHM1 and P86L-CALHM, upon Abeta treatment, on the following: (i) the intracellular Ca2+signal pathway; (ii) cell survival proteins ERK1/2 and Ca2+/cAMP response element binding (CREB); and (iii) cell vulnerability after treatment with Abeta. Using aequorins to measure the effect of nuclear Ca2+concentrations ([Ca2+]n ) and cytosolic Ca2+concentrations ([Ca2+]c ) on Ca2+entry conditions, we observed that baseline [Ca2+]n was higher in CALHM1 and P86L-CALHM1 cells than in control cells. Moreover, exposure to Abeta affected [Ca2+]c levels in HeLa cells overexpressing CALHM1 and P86L-CALHM1 compared with control cells. Treatment with Abeta elicited a significant decrease in the cell survival proteins p-ERK and p-CREB, an increase in the activity of caspases 3 and 7, and more frequent cell death by inducing early apoptosis in P86L-CALHM1-overexpressing cells than in CALHM1 or control cells. These results suggest that in the presence of Abeta, P86L-CALHM1 shifts the balance between neurodegeneration and neuronal survival toward the stimulation of pro-cytotoxic pathways, thus potentially contributing to its deleterious effects in AD.
26416646	0	6	CALHM1	Gene	255022
26416646	28	32	P86L	ProteinMutation	tmVar:p|SUB|P|86|L;HGVS:p.P86L;VariantGroup:0;CorrespondingGene:255022;RS#:2986017;CorrespondingSpecies:9606;CA#:5674757
26416646	56	60	Ca2+	Chemical	-
26416646	157	169	amyloid beta	Gene	351
26416646	195	199	Ca2+	Gene	760
26416646	207	213	CALHM1	Gene	255022
26416646	245	249	P86L	ProteinMutation	tmVar:p|SUB|P|86|L;HGVS:p.P86L;VariantGroup:0;CorrespondingGene:255022;RS#:2986017;CorrespondingSpecies:9606;CA#:5674757
26416646	250	256	CALHM1	Gene	255022
26416646	298	317	Alzheimer's disease	Disease	MESH:D000544
26416646	319	321	AD	Disease	MESH:D000544
26416646	324	328	P86L	ProteinMutation	tmVar:p|SUB|P|86|L;HGVS:p.P86L;VariantGroup:0;CorrespondingGene:255022;RS#:2986017;CorrespondingSpecies:9606;CA#:5674757
26416646	329	335	CALHM1	Gene	255022
26416646	360	372	amyloid beta	Gene	351
26416646	374	379	Abeta	Gene	351
26416646	400	404	Ca2+	Chemical	-
26416646	517	523	CALHM1	Gene	255022
26416646	528	532	P86L	ProteinMutation	tmVar:p|SUB|P|86|L;HGVS:p.P86L;VariantGroup:0;CorrespondingGene:255022;RS#:2986017;CorrespondingSpecies:9606;CA#:5674757
26416646	545	550	Abeta	Gene	351
26416646	602	606	Ca2+	Chemical	-
26416646	650	656	ERK1/2	Gene	5595;5594
26416646	661	695	Ca2+/cAMP response element binding	Gene	1385
26416646	697	701	CREB	Gene	1385
26416646	754	759	Abeta	Gene	351
26416646	810	814	Ca2+	Chemical	-
26416646	831	835	Ca2+	Gene	760
26416646	854	858	Ca2+	Chemical	-
26416646	875	879	Ca2+	Gene	760
26416646	887	891	Ca2+	Chemical	-
26416646	936	940	Ca2+	Gene	760
26416646	957	963	CALHM1	Gene	255022
26416646	968	972	P86L	ProteinMutation	tmVar:p|SUB|P|86|L;HGVS:p.P86L;VariantGroup:0;CorrespondingGene:255022;RS#:2986017;CorrespondingSpecies:9606;CA#:5674757
26416646	973	979	CALHM1	Gene	255022
26416646	1031	1036	Abeta	Gene	351
26416646	1047	1051	Ca2+	Gene	760
26416646	1064	1068	HeLa	CellLine	CVCL:0030
26416646	1090	1096	CALHM1	Gene	255022
26416646	1101	1105	P86L	ProteinMutation	tmVar:p|SUB|P|86|L;HGVS:p.P86L;VariantGroup:0;CorrespondingGene:255022;RS#:2986017;CorrespondingSpecies:9606;CA#:5674757
26416646	1106	1112	CALHM1	Gene	255022
26416646	1157	1162	Abeta	Gene	351
26416646	1227	1230	ERK	Gene	5594
26416646	1237	1241	CREB	Gene	1385
26416646	1274	1290	caspases 3 and 7	Gene	836;840
26416646	1352	1356	P86L	ProteinMutation	tmVar:p|SUB|P|86|L;HGVS:p.P86L;VariantGroup:0;CorrespondingGene:255022;RS#:2986017;CorrespondingSpecies:9606;CA#:5674757
26416646	1357	1363	CALHM1	Gene	255022
26416646	1393	1399	CALHM1	Gene	255022
26416646	1464	1469	Abeta	Gene	351
26416646	1471	1475	P86L	ProteinMutation	tmVar:p|SUB|P|86|L;HGVS:p.P86L;VariantGroup:0;CorrespondingGene:255022;RS#:2986017;CorrespondingSpecies:9606;CA#:5674757
26416646	1476	1482	CALHM1	Gene	255022
26416646	1510	1527	neurodegeneration	Disease	MESH:D019636
26416646	1580	1589	cytotoxic	Disease	MESH:D064420
26416646	1660	1662	AD	Disease	MESH:D000544
26416646	Positive_Correlation	MESH:D064420	RS#:2986017;HGVS:p.P86L;CorrespondingGene:255022
26416646	Association	MESH:D000544	351
26416646	Association	MESH:D019636	RS#:2986017;HGVS:p.P86L;CorrespondingGene:255022
26416646	Positive_Correlation	351	840
26416646	Positive_Correlation	MESH:D000544	RS#:2986017;HGVS:p.P86L;CorrespondingGene:255022
26416646	Association	255022	760
26416646	Association	1385	255022
26416646	Negative_Correlation	351	5594
26416646	Association	MESH:D019636	255022
26416646	Association	MESH:D064420	255022
26416646	Negative_Correlation	1385	351
26416646	Association	MESH:D000544	255022
26416646	Positive_Correlation	351	836
26416646	Association	351	760
26416646	Association	255022	5594
26416646	Positive_Correlation	255022	351
26416646	Association	MESH:D064420	255022
26416646	Association	MESH:D019636	255022
26416646	Association	MESH:D000544	255022

